XML 19 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Organization (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Feb. 12, 2018
USD ($)
$ / shares
shares
Nov. 30, 2019
USD ($)
$ / shares
shares
Jul. 31, 2018
USD ($)
$ / shares
shares
Jan. 31, 2018
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Feb. 11, 2018
shares
Subsidiary, Sale of Stock [Line Items]              
Stock split, conversion ratio       1.6527      
Sale of stock, offering price (in dollars per share) | $ / shares $ 12.00   $ 20.00        
Proceeds from initial public offering, net of underwriters fees | $ $ 56,330       $ 0 $ 56,330  
Common stock, shares authorized (in shares) 100,000,000       100,000,000 100,000,000  
Common stock, par value (in dollars per share) | $ / shares $ 0.00001       $ 0.00001 $ 0.00001  
Preferred stock, shares authorized (in shares) 10,000,000       10,000,000 10,000,000  
Preferred stock, par value (in dollars per share) | $ / shares $ 0.00001       $ 0.00001 $ 0.00001  
Number of shares sold upon completion of follow-on public offering (in shares)     3,600,000        
Proceeds from follow-on offering, net of underwriting fees | $     $ 67,680   $ 73,315 $ 67,680  
Net loss | $         90,034 46,867  
Cash used in operations | $         93,383 25,667  
Cash and cash equivalents | $         109,892 93,162  
Short-term investments | $         19,911 0  
Accumulated deficit | $         $ 213,059 $ 123,025  
Majority Shareholder | Evolus, Inc.              
Subsidiary, Sale of Stock [Line Items]              
Ownership percentage         25.80% 56.00%  
IPO              
Subsidiary, Sale of Stock [Line Items]              
Number of shares issued in transaction (in shares) 5,047,514            
Underwriters Option              
Subsidiary, Sale of Stock [Line Items]              
Number of shares issued in transaction (in shares) 47,514            
Number of shares sold upon completion of follow-on public offering (in shares)     600,000        
Common Stock | Underwriters Option              
Subsidiary, Sale of Stock [Line Items]              
Number of shares issued in transaction (in shares)   782,550          
Common Stock | Follow-on Offering              
Subsidiary, Sale of Stock [Line Items]              
Number of shares issued in transaction (in shares)   5,999,550          
Sale of stock, offering price (in dollars per share) | $ / shares   $ 13.00          
Proceeds from follow-on offering, net of underwriting fees | $   $ 73,315          
Common Stock | IPO              
Subsidiary, Sale of Stock [Line Items]              
Number of shares sold upon completion of follow-on public offering (in shares)         5,999,550 5,047,514  
Common Stock | Follow-on Offering              
Subsidiary, Sale of Stock [Line Items]              
Number of shares sold upon completion of follow-on public offering (in shares)         288,124 3,600,000  
Common Stock | Series A Convertible Preferred Stock              
Subsidiary, Sale of Stock [Line Items]              
Preferred stock, shares authorized (in shares)         0   2,500,000
Common Stock | Series A Convertible Preferred Stock | IPO              
Subsidiary, Sale of Stock [Line Items]              
Number of shares of convertible preferred stock converted (in shares) 2,065,875